Prelude Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Prelude Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,607	Closed	-$4.94M	–	2367
2015 Q1	$4.94M	Buy	28,607 +20,584	+257%	+$3.02M	0.69%	12
2014 Q4	$922K	Buy	+8,023	New	+$972K	0.14%	170
2014 Q2	–	Sell	-6,730	Closed	-$697K	–	2412
2014 Q1	$697K	Buy	6,730 +4,315	+179%	+$442K	0.09%	295
2013 Q4	$217K	Hold	2,415	–	–	0.04%	596
2013 Q3	$162K	Sell	2,415 -3,647	-60%	-$251K	0.03%	598
2013 Q2	$401K	Buy	+6,062	New	+$347K	0.09%	297

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Prelude Capital Management's SLXP Position: Q2 2015 in Review

Prelude Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 28,607 shares — an estimated $4.94M sold.

Prelude Capital Management first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $4.94M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Prelude Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Prelude Capital Management sold 28,607 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $4.94M.
Prelude Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
Prelude Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $4.94M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Prelude Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.